Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × epothilone B × Clear all

NCT00411528 2020-12-17

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00035113 2017-02-09

EPO906 Therapy in Patients With Prostate Cancer

Phase 2 Completed

Carcinoma, Neoplasms, Prostatic Neoplasms